1-4 of 4
Edwin P. Alyea
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Angiogenic Cytokines Are Antibody Targets During Graft-versus-Leukemia Reactions

Matthias Piesche, Vincent T. Ho, Haesook Kim, Yukoh Nakazaki, Michael Nehil, Nasser K. Yaghi, Dmitriy Kolodin, Jeremy Weiser, Peter Altevogt, Helena Kiefel, Edwin P. Alyea, Joseph H. Antin, Corey Cutler, John Koreth, Christine Canning, Jerome Ritz, Robert J. Soiffer, Glenn Dranoff
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (5): 1010–1018.
https://doi.org/10.1158/1078-0432.CCR-14-1956
Published: 01 March 2015
View article titled, Angiogenic Cytokines Are Antibody Targets During Graft-versus-Leukemia Reactions
Open the PDF for Angiogenic Cytokines Are Antibody Targets During Graft-versus-Leukemia Reactions in another window
Includes: Supplementary data
Journal Articles

Graft-versus-Leukemia Antigen CML66 Elicits Coordinated B-Cell and T-Cell Immunity after Donor Lymphocyte Infusion

Wandi Zhang, Jaewon Choi, Wanyong Zeng, Shelby A. Rogers, Edwin P. Alyea, James G. Rheinwald, Christine M. Canning, Vladimir Brusic, Tetsuro Sasada, Ellis L. Reinherz, Jerome Ritz, Robert J. Soiffer, Catherine J. Wu
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (10): 2729–2739.
https://doi.org/10.1158/1078-0432.CCR-10-0415
Published: 13 May 2010
View article titled, Graft-versus-Leukemia Antigen CML66 Elicits Coordinated B-Cell and T-Cell Immunity after Donor Lymphocyte Infusion
Open the PDF for Graft-versus-Leukemia Antigen CML66 Elicits Coordinated B-Cell and T-Cell Immunity after Donor Lymphocyte Infusion in another window
Includes: Supplementary data
Journal Articles

Extended Follow-up of Patients Treated with Imatinib Mesylate (Gleevec) for Chronic Myelogenous Leukemia Relapse after Allogeneic Transplantation: Durable Cytogenetic Remission and Conversion to Complete Donor Chimerism without Graft- versus -Host Disease

Daniel J. DeAngelo, Ephraim P. Hochberg, Edwin P. Alyea, Janina Longtine, Stephanie Lee, Ilene Galinsky, Ben Parekkedon, Jerome Ritz, Joseph H. Antin, Richard M. Stone, Robert J. Soiffer
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (15): 5065–5071.
https://doi.org/10.1158/1078-0432.CCR-03-0580
Published: 05 August 2004
View article titled, Extended Follow-up of Patients Treated with Imatinib Mesylate (Gleevec) for Chronic Myelogenous Leukemia Relapse after Allogeneic Transplantation: <subtitle>Durable Cytogenetic Remission and Conversion to Complete Donor Chimerism without Graft- <em>versus</em> -Host Disease</subtitle>
Open the PDF for Extended Follow-up of Patients Treated with Imatinib Mesylate (Gleevec) for Chronic Myelogenous Leukemia Relapse after Allogeneic Transplantation: <subtitle>Durable Cytogenetic Remission and Conversion to Complete Donor Chimerism without Graft- <em>versus</em> -Host Disease</subtitle> in another window
Journal Articles

Infusion of CD4+ Donor Lymphocytes Induces the Expansion of CD8+ Donor T Cells with Cytolytic Activity Directed against Recipient Hematopoietic Cells

Emmanuel Zorn, Kathy S. Wang, Ephraim P. Hochberg, Christine Canning, Edwin P. Alyea, Robert J. Soiffer, Jerome Ritz
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (7): 2052–2060.
Published: 01 July 2002
View article titled, Infusion of CD4+ Donor Lymphocytes Induces the Expansion of CD8+ Donor T Cells with Cytolytic Activity Directed against Recipient Hematopoietic Cells
Open the PDF for Infusion of CD4+ Donor Lymphocytes Induces the Expansion of CD8+ Donor T Cells with Cytolytic Activity Directed against Recipient Hematopoietic Cells in another window